Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Eli Lilly Corp. buy gerihouse

Start price
€71.74
10.11.16 / 50%
Target price
€85.00
18.04.17
Performance (%)
8.26%
End price
€77.18
18.04.17
Summary
This prediction ended on 18.04.17 with a price of €77.18. The BUY prediction by gerihouse finished with a performance of 8.26%. gerihouse has a follow-up prediction for Eli Lilly Corp. where he still thinks Eli Lilly Corp. is a Buy. gerihouse has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Eli Lilly Corp. 0.543% 0.543% 100.938% 342.207%
iShares Core DAX® 2.594% -1.158% 14.782% 16.813%
iShares Nasdaq 100 3.553% -1.727% 43.265% 44.227%
iShares Nikkei 225® 0.687% -8.354% 18.454% 1.361%
iShares S&P 500 2.209% -0.942% 31.361% 42.812%

According to gerihouse what are the pros and cons of Eli Lilly Corp. for the foreseeable future?

Pros
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Future proof or reliable business model
Small cyclical dependencies
Well known brand
Revenue growth >5% per year expected
Cons

Comments by gerihouse for this prediction

In the thread Eli Lilly Corp. diskutieren
Prediction Buy
Perf. (%) 8.26%
Target price 85.000
Change
Ends at 18.04.17

weltweit führendes pharma Unternehmen

Immer wieder einen Kauf wert. Gute Dividenenaktie, für Langfristanleger!


Der Pharmakonzern Eli Lilly (ISIN: US5324571083, NYSE: LLY) zahlt eine Dividende von 51 US-Cents je Aktie an seine Investoren aus. Auf Jahressicht erhalten die Aktionäre 2,04 US-Dollar. Dies entspricht einer aktuellen Dividendenrendite in Höhe von 2,60 Prozent beim derzeitigen Aktienkurs von 78,44 US-Dollar (Stand: 17. Oktober 2016).

Eli Lilly zahlt seit 1885 ununterbrochen eine Dividende an seine Aktionäre aus. Die Aktionäre erhalten die nächste Dividendenzahlung am 9. Dezember 2016 (Record date: 15. November 2016). Seit Jahresanfang liegt die Aktie an der Wall Street mit 6,91 Prozent im Minus.

Eli Lilly and Company gehört zu den weltweit führenden pharmazeutischen Unternehmen und ist seit über 50 Jahren auch in Deutschland vertreten. Das Unternehmen mit Firmensitz in Indianapolis wurde 1876 von dem Pharmakologen, Offizier und Unternehmer Eli Lilly in Indianapolis gegründet.

Saskia Haaker, Redaktion MyDividends.de

Prediction Buy
Perf. (%) 8.26%
Target price 85.000
Change
Ends at 18.04.17

(Stop Loss Kurs erreicht)

Current prediction by gerihouse for Eli Lilly Corp.

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€546.50
16.11.23
€740.00
16.11.24
25.60%
26.04.24

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative

Stopped prediction by gerihouse for Eli Lilly Corp.

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€370.05
04.11.22
€610.00
04.11.23
44.17%
05.11.23

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€213.80
18.01.22
€350.00
18.01.23
47.33%
23.09.22

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€173.98
25.01.21
€250.00
25.01.22
23.00%
17.01.22

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€126.32
18.03.20
€150.00
12.10.20
6.54%
12.10.20

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€98.78
13.10.19
€120.00
26.10.19
0.30%
26.10.19

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€104.32
06.09.19
€120.00
13.10.19
-5.58%
13.10.19

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€103.80
24.06.19
€130.79
06.09.19
0.94%
06.09.19

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€102.30
18.04.19
€120.00
24.05.19
3.46%
24.05.19

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€106.63
24.01.19
€126.28
04.04.19
6.26%
04.04.19

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€71.74
10.05.18
€99.22
06.09.18
32.15%
06.09.18

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€68.59
31.08.17
€80.00
10.11.17
3.37%
10.11.17

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€63.10
24.03.16
€90.00
08.08.16
16.05%
08.08.16

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€71.93
13.10.15
€90.20
04.01.16
4.66%
04.01.16

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€65.85
05.05.15
€83.00
22.07.15
19.78%
22.07.15

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€49.89
11.09.14
€60.00
24.11.14
8.90%
24.11.14

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€39.56
09.10.12
€45.00
21.02.13
5.46%
21.02.13

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€34.30
04.07.12
€40.00
05.09.12
8.03%
05.09.12

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative